• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过使用乳糖作为冻干介质提高脑膜炎球菌多糖疫苗的稳定性。

Enhanced stability of meningococcal polysaccharide vaccines by using lactose as a menstruum for lyophilization.

作者信息

Tiesjema R H, Beuvery E C, te Pas B J

出版信息

Bull World Health Organ. 1977;55(1):43-8.

PMID:408022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2366609/
Abstract

A comparison is made between lactose and mannitol as additives for the lyophilization of meningococcal polysaccharide vaccines. From the stability data obtained on storage at high temperatures, it is concluded that vaccines containing lactose as a menstruum for lyophilization are much more stable than vaccines prepared with the currently used additive, mannitol. The enhanced stability of these vaccines makes it possible to store also group A vaccines at 5 degrees C instead of at -20 degrees C, and to use them in places without freezing facilities.

摘要

对乳糖和甘露醇作为脑膜炎球菌多糖疫苗冻干添加剂进行了比较。从高温储存获得的稳定性数据得出结论,含有乳糖作为冻干溶媒的疫苗比用目前使用的添加剂甘露醇制备的疫苗稳定得多。这些疫苗稳定性的提高使得A群疫苗也可以在5摄氏度而不是-20摄氏度下储存,并可在没有冷冻设施的地方使用。

相似文献

1
Enhanced stability of meningococcal polysaccharide vaccines by using lactose as a menstruum for lyophilization.通过使用乳糖作为冻干介质提高脑膜炎球菌多糖疫苗的稳定性。
Bull World Health Organ. 1977;55(1):43-8.
2
Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines.脑膜炎球菌感染。4. A群和C群多糖疫苗的稳定性。
Bull World Health Organ. 1971;45(3):287-90.
3
[Observations on the reactions and preventive efficacy of lyophilized group A meningococcal polysaccharide vaccine (author's transl)].冻干A群脑膜炎球菌多糖疫苗的反应及预防效果观察(作者译)
Zhonghua Yu Fang Yi Xue Za Zhi. 1982 Jan;16(1):39-41.
4
Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.一种新型四价脑膜炎球菌多糖疫苗的免疫原性和副作用
Bull World Health Organ. 1983;61(2):317-23.
5
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.B群脑膜炎奈瑟菌的荚膜多糖作为疫苗开发的载体。
Contrib Microbiol Immunol. 1989;10:151-65.
6
Meningococcal polysaccharide vaccines.脑膜炎球菌多糖疫苗
Hosp Pharm. 1977 Apr;12(4):201.
7
Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.意大利新兵中A群和C群脑膜炎奈瑟菌荚膜多糖疫苗的血清抗体情况
Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):39-41.
8
[Immunity against Neisseria meningitidis in different population groups].不同人群中针对脑膜炎奈瑟菌的免疫力
Rev Cubana Med Trop. 1989 Jan-Apr;41(1):135-47.
9
Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides.两种四价(ACYW135)脑膜炎球菌疫苗在婴幼儿中的评估:一项比较O-乙酰基阴性和O-乙酰基阳性C群多糖免疫原性的临床研究。
Pediatrics. 1985 Jul;76(1):91-6.
10
Meningococcal disease: a review on available vaccines and vaccines in development.脑膜炎球菌病:现有疫苗及正在研发的疫苗综述
Minerva Med. 2007 Oct;98(5):575-89.

引用本文的文献

1
Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.结合到重组金黄色葡萄球菌肠毒素C1上的脑膜炎奈瑟菌A群和W135群荚膜多糖缀合物:制备、理化特性及在小鼠中的免疫学特性
Infect Immun. 2005 Dec;73(12):7887-93. doi: 10.1128/IAI.73.12.7887-7893.2005.
2
Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.A群脑膜炎球菌荚膜多糖结合物的制备与表征及其在小鼠体内免疫原性的评估
Infect Immun. 2003 Sep;71(9):5115-20. doi: 10.1128/IAI.71.9.5115-5120.2003.
3
Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens.针对B群脑膜炎奈瑟菌疾病的防护:可溶性蛋白和蛋白-多糖免疫原的制备。
Infect Immun. 1982 Jul;37(1):271-80. doi: 10.1128/iai.37.1.271-280.1982.
4
Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.C群脑膜炎球菌多糖-破伤风类毒素结合物作为新一代疫苗的制备及免疫化学特性分析
Infect Immun. 1983 Apr;40(1):39-45. doi: 10.1128/iai.40.1.39-45.1983.
5
Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide.用与外膜蛋白复合的多糖对小鼠进行疫苗接种以获得针对B群脑膜炎奈瑟菌的免疫和保护:与纯化的B多糖的比较。
Infect Immun. 1985 Feb;47(2):527-33. doi: 10.1128/iai.47.2.527-533.1985.

本文引用的文献

1
Growth Requirements of the Meningococcus.脑膜炎球菌的生长需求
J Bacteriol. 1942 Jun;43(6):757-61. doi: 10.1128/jb.43.6.757-761.1942.
2
Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.唾液酸的定量测定。II. 比色间苯二酚 - 盐酸法。
Biochim Biophys Acta. 1957 Jun;24(3):604-11. doi: 10.1016/0006-3002(57)90254-8.
3
Peroxidase-labeled antibody. A new method of conjugation.过氧化物酶标记抗体。一种新的偶联方法。
J Histochem Cytochem. 1974 Dec;22(12):1084-91. doi: 10.1177/22.12.1084.
4
The influence of heterologous combinations of antiserum and enzyme-labeled estrogen on the characteristics of estrogen enzyme-immunoassays.抗血清与酶标记雌激素的异源组合对雌激素酶免疫测定特性的影响。
Immunochemistry. 1975 Aug;12(8):667-70. doi: 10.1016/0019-2791(75)90213-x.